218 related articles for article (PubMed ID: 8719034)
21. Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme.
Dorer FE; Kahn JR; Lentz KE; Levine M; Skeggs LT
Biochem Pharmacol; 1975 May; 24(10):1137-9. PubMed ID: 168899
[No Abstract] [Full Text] [Related]
22. Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research.
Cleland JG; Morgan K
Curr Opin Cardiol; 1996 May; 11(3):252-62. PubMed ID: 8835867
[TBL] [Abstract][Full Text] [Related]
23. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes.
Haulică I; Bild W; Rădăşanu O
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):167-72. PubMed ID: 19292099
[TBL] [Abstract][Full Text] [Related]
24. Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.
van Kesteren CA; Saris JJ; Dekkers DH; Lamers JM; Saxena PR; Schalekamp MA; Danser AH
Cardiovasc Res; 1999 Jul; 43(1):148-56. PubMed ID: 10536699
[TBL] [Abstract][Full Text] [Related]
25. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
26. The physiological significance of the alternative pathways of angiotensin II production.
Kramkowski K; Mogielnicki A; Buczko W
J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
[TBL] [Abstract][Full Text] [Related]
27. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.
von Lutterotti N; Catanzaro DF; Sealey JE; Laragh JH
Circulation; 1994 Jan; 89(1):458-70. PubMed ID: 8281681
[TBL] [Abstract][Full Text] [Related]
28. Novel aspects of the renin-angiotensin-aldosterone-system.
Wolf G
Front Biosci; 2008 May; 13():4993-5005. PubMed ID: 18508564
[TBL] [Abstract][Full Text] [Related]
29. [The renin-angiotensin system of the brain].
Wiecek A
Pol Arch Med Wewn; 1983 Jan; 69(1):69-78. PubMed ID: 6310531
[No Abstract] [Full Text] [Related]
30. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
Weir MR; Dzau VJ
Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
[TBL] [Abstract][Full Text] [Related]
31. Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats.
Aguilera G; Catt KJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):4057-61. PubMed ID: 211515
[TBL] [Abstract][Full Text] [Related]
32. The brain renin--angiotensin system.
Ganten D; Speck G; Schelling P; Unger T
Adv Biochem Psychopharmacol; 1981; 28():359-72. PubMed ID: 6259907
[No Abstract] [Full Text] [Related]
33. Vascular renin-angiotensin system and vascular protection.
Dzau VJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
[TBL] [Abstract][Full Text] [Related]
34. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors.
Janke J; Engeli S; Gorzelniak K; Luft FC; Sharma AM
Diabetes; 2002 Jun; 51(6):1699-707. PubMed ID: 12031955
[TBL] [Abstract][Full Text] [Related]
35. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
36. [Renin-angiotensin-aldosterone system in thyroid disorders].
Marcisz C
Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270
[TBL] [Abstract][Full Text] [Related]
37. The renin-angiotensin system and vascular hypertrophy.
Rosendorff C
J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
[TBL] [Abstract][Full Text] [Related]
38. Measurement of the renin-angiotensin system in heart failure.
Kim SD
Biol Res Nurs; 2000 Jan; 1(3):210-26. PubMed ID: 11232216
[TBL] [Abstract][Full Text] [Related]
39. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
40. The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.
Raynolds MV; Perryman MB
Eur Heart J; 1995 Nov; 16 Suppl K():23-30. PubMed ID: 8869132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
